Richard Bourgon
Freenome (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation, RNA modifications and cancer
Most-Cited Works
- → TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells(2018)5,347 cited
- → Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial(2016)3,687 cited
- → Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial(2016)2,185 cited
- → Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer(2012)1,088 cited
- → Cross-tissue organization of the fibroblast lineage(2021)1,042 cited
- → Diverse somatic mutation patterns and pathway alterations in human cancers(2010)1,025 cited
- → Recurrent R-spondin fusions in colon cancer(2012)969 cited
- → Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy(2019)817 cited
- → Peripheral T cell expansion predicts tumour infiltration and clinical response(2020)777 cited
- → Independent filtering increases detection power for high-throughput experiments(2010)772 cited